Author

C.-G. Shen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

H.-L. Xiong· 1 shared J. Ma· 1 shared J. Zhang· 1 shared J.-L. Cao· 1 shared N.-S. Xia· 1 shared Q. Yuan· 1 shared S.-X. Ge· 1 shared T. Shi· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

H.-L. Xiong

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Several FDA-approved drugs effectively inhibit SARS-CoV-2 infection in vitro

H.-L. Xiong, J.-L. Cao, C.-G. Shen, J. Ma, X. Qiao, T. Shi, Y. Yang, S.-X. Ge, J. Zhang, T.-Y. Zhang, Q. Yuan, N.-S. Xia

This study evaluates 1403 FDA-approved drugs for SARS-CoV-2 inhibition using pseudovirus and authentic virus assays, identifying four compounds with potent effects and a synergistic combination.

bioRxiv · Jun 5, 2020Microbiology